New Delhi, May 06: Indian companies have announced a record $20.5 billion in investments in the United States at the 2026 SelectUSA Investment Summit in Maryland, underscoring deepening economic ties between the two countries.
According to the U.S. Embassy in New Delhi, the investments span key sectors such as pharmaceuticals, advanced manufacturing, energy infrastructure and emerging technologies, and are expected to create thousands of jobs while strengthening supply chains.
A major share of the investment is led by the pharmaceutical sector, with more than $19.1 billion earmarked for manufacturing, research and development, and new facilities. This includes a proposed $11.75 billion acquisition of Organon & Co. by Sun Pharmaceutical Industries.
In addition, 12 Indian companies announced over $1.1 billion in new greenfield and expansion projects across multiple US states, covering manufacturing, technology and engineering sectors. These include investments by firms such as Sterlite Technologies and Jindal Pipe.
Speaking at the summit, US Ambassador Sergio Gor said the investments reflect efforts to boost bilateral trade to $500 billion by 2030 through “fair, balanced and mutually beneficial trade”.
The summit, organised under the SelectUSA Investment Summit initiative, connects global investors with opportunities across the United States and facilitates business expansion and partnerships.
Officials said the latest announcements mark the largest investment commitments from India at the event and highlight the growing role of Indian companies in driving economic growth and innovation in the US.
